Spots Global Cancer Trial Database for adenomatous polyposis coli
Every month we try and update this database with for adenomatous polyposis coli cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis | NCT00808743 | Familial Adenom... Duodenal Neopla... Duodenal Polyps | Celecoxib Ursodeoxycholic... Placebo | 18 Years - 70 Years | Radboud University Medical Center | |
| Sirolimus and Familial Adenomatous Polyposis (FAP) | NCT03095703 | Adenomatous Pol... | Sirolimus | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients | NCT01187901 | Adenomatous Pol... | Erlotinib Sulindac Placebo A Placebo B | 18 Years - 69 Years | University of Utah | |
| A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis | NCT05014360 | Adenomatous Pol... | JNJ-64251330 | 18 Years - | Janssen Research & Development, LLC | |
| Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP) | NCT00585312 | Adenomatous Pol... | Celecoxib Placebo | 10 Years - 17 Years | Pfizer | |
| A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients | NCT01187901 | Adenomatous Pol... | Erlotinib Sulindac Placebo A Placebo B | 18 Years - 69 Years | University of Utah | |
| Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics | NCT03027401 | Neoplasms Adenomatous Pol... Neurofibroma, P... Myelodysplastic... | - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis | NCT04948398 | Adenomatous Pol... | Guselkumab | - | Janssen Research & Development, LLC | |
| FOG-001 in Locally Advanced or Metastatic Solid Tumors | NCT05919264 | Cancer Colorectal Canc... Solid Tumor Locally Advance... Metastatic Canc... Gastric Cancer Non-small Cell ... Non-small Cell ... Non-small Cell ... Non-small Cell ... Non-Small Cell ... Gastroesophagea... WNT Pathway β-catenin Beta-catenin Adenomatous Pol... APC | FOG-001 FOG-001 | 18 Years - | Fog Pharmaceuticals, Inc. | |
| Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics | NCT03027401 | Neoplasms Adenomatous Pol... Neurofibroma, P... Myelodysplastic... | - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics | NCT03027401 | Neoplasms Adenomatous Pol... Neurofibroma, P... Myelodysplastic... | - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| A Study of Guselkumab in Participants With Familial Adenomatous Polyposis | NCT03649971 | Adenomatous Pol... | Guselkumab Placebo | 18 Years - | Janssen Research & Development, LLC | |
| Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis | NCT00808743 | Familial Adenom... Duodenal Neopla... Duodenal Polyps | Celecoxib Ursodeoxycholic... Placebo | 18 Years - 70 Years | Radboud University Medical Center | |
| Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW | NCT02113202 | Adenomatous Pol... | Bevacizumab-IRD... Near infrared f... | 18 Years - 70 Years | University Medical Center Groningen | |
| A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients | NCT01187901 | Adenomatous Pol... | Erlotinib Sulindac Placebo A Placebo B | 18 Years - 69 Years | University of Utah | |
| Sirolimus and Familial Adenomatous Polyposis (FAP) | NCT03095703 | Adenomatous Pol... | Sirolimus | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis | NCT00319007 | Adenomatous Pol... | Sulindac (drug) VSL#3 (probioti... Inulin (probiot... | 16 Years - | Radboud University Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
